Doubly randomized delayed-start design for enrichment studies with responders or nonresponders.
High placebo response has been a major source of bias and is difficult to deal with in many central nervous system (CNS) clinical trials. This bias has led to a high failure rate in mood disorder trials even with known effective drugs. For cancer trials, the traditional parallel group design biases the inference on the maintenance effect of the new drug with the traditional time-to-treatment failure analysis. To minimize bias, we propose a doubly randomized delayed-start design for clinical trials with enrichment. The design consists of two periods. In the first period, patients can be randomized to receive several doses of a new drug or a control. In the second period, control patients of the first period of an enriched population can be rerandomized to receive the same or fewer doses of the new drug or to continue on the control. Depending on the clinical needs, different randomization ratios can be applied to the two periods. The essential feature is that the design is naturally adaptive because of the randomization for the second period. As a result, other aspects of the second period, such as the sample size, can be modified adaptively when an interim analysis is set up for the first period. At the end of the trial, response data from both randomizations are combined in an integrated analysis. Because of the enrichment in the second period, the design increases the probability of trial success and, in addition, reduces the required sample size. Thus, for clinical development, the design offers greater efficiency.
Janssen Research & Development, LLC, Raritan, NJ 08869, USA. QLiu2@its.jnj.com
Qing
Q
Liu
Pilar
P
Lim
Jaskaran
J
Singh
David
D
Lewin
Barry
B
Schwab
Justine
J
Kent
D000465:Algorithms; D015982:Bias; D002493:Central Nervous System Diseases / Q000188:drug therapy; D018592:Cross-Over Studies; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D010919:Placebos; D011336:Probability; D016032:Randomized Controlled Trials as Topic / Q000379:methods / Q000706:statistics & numerical data*; D012107:Research Design / Q000706:statistics & numerical data; D018401:Sample Size
D010919:Placebos